secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2022-03-29T23:59:59+00:00
Accession:  0001534969-22-000033
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics Q4 2021 revenue $26k, net loss $12.5M; losses widen as commercial ops scale
--------------------------------------------------------------------------------

- Q4 2021 revenue rose to $26k from $6k YoY; net loss of $12.5M vs $5.4M.
- Full-year 2021 revenue $82k, total operating expenses $35.5M (up from $18M).
- Cash and securities totaled $139.9M as of Dec 31, 2021.
- CMS set Medicare payment rate of $750 for PreTRM test; added to NASDAQ Biotechnology Index.
- R&D spend increased to $3.1M in Q4; SG&A jumped to $9.5M on higher headcount and public company costs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000153496922000033/0001534969-22-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000153496922000033/sera-20220329.htm
  HTML page:      https://secwatch.observer/filing/0001534969-22-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer